Effective targeting of the tumor microenvironment for cancer therapy.
BACKGROUND: The tumor microenvironment is an emerging source of novel therapeutic targets in cancer. The glycosaminoglycan hyaluronan (HA) accumulates in 20-30% of tumors and is often associated with poor prognosis. MATERIALS AND METHODS: We developed a digitized, semiquantitative scoring system fo...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
_version_ | 1826283722231513088 |
---|---|
author | Jiang, P Li, X Thompson, C Huang, Z Araiza, F Osgood, R Wei, G Feldmann, M Frost, G Shepard, H |
author_facet | Jiang, P Li, X Thompson, C Huang, Z Araiza, F Osgood, R Wei, G Feldmann, M Frost, G Shepard, H |
author_sort | Jiang, P |
collection | OXFORD |
description | BACKGROUND: The tumor microenvironment is an emerging source of novel therapeutic targets in cancer. The glycosaminoglycan hyaluronan (HA) accumulates in 20-30% of tumors and is often associated with poor prognosis. MATERIALS AND METHODS: We developed a digitized, semiquantitative scoring system for tumor-associated HA content, then grouped tumors (from animal models or patients) according to the degree of HA accumulation (HA+1,2,3). The antitumor response to HA-depletion by pegylated PH20 hyaluronidase (PEGPH20) was then characterized as a function of HA accumulation. RESULTS: Semiquantitative grouping of tumors demonstrated that HA accumulation predicts the response of tumors in animal models to PEGPH20. Prospective analysis of HA content was used to predict response to PEGPH20 of squamous cell-type explants from patients with non-small cell lung cancer in nude mice. CONCLUSION: Measurement of HA is a viable biomarker approach for predicting antitumor response in animal models to the HA-depleting agent, PEGPH20. |
first_indexed | 2024-03-07T01:03:10Z |
format | Journal article |
id | oxford-uuid:8a6928fa-9b0c-4fda-a6f2-3284e1e94f48 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T01:03:10Z |
publishDate | 2012 |
record_format | dspace |
spelling | oxford-uuid:8a6928fa-9b0c-4fda-a6f2-3284e1e94f482022-03-26T22:31:23ZEffective targeting of the tumor microenvironment for cancer therapy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8a6928fa-9b0c-4fda-a6f2-3284e1e94f48EnglishSymplectic Elements at Oxford2012Jiang, PLi, XThompson, CHuang, ZAraiza, FOsgood, RWei, GFeldmann, MFrost, GShepard, H BACKGROUND: The tumor microenvironment is an emerging source of novel therapeutic targets in cancer. The glycosaminoglycan hyaluronan (HA) accumulates in 20-30% of tumors and is often associated with poor prognosis. MATERIALS AND METHODS: We developed a digitized, semiquantitative scoring system for tumor-associated HA content, then grouped tumors (from animal models or patients) according to the degree of HA accumulation (HA+1,2,3). The antitumor response to HA-depletion by pegylated PH20 hyaluronidase (PEGPH20) was then characterized as a function of HA accumulation. RESULTS: Semiquantitative grouping of tumors demonstrated that HA accumulation predicts the response of tumors in animal models to PEGPH20. Prospective analysis of HA content was used to predict response to PEGPH20 of squamous cell-type explants from patients with non-small cell lung cancer in nude mice. CONCLUSION: Measurement of HA is a viable biomarker approach for predicting antitumor response in animal models to the HA-depleting agent, PEGPH20. |
spellingShingle | Jiang, P Li, X Thompson, C Huang, Z Araiza, F Osgood, R Wei, G Feldmann, M Frost, G Shepard, H Effective targeting of the tumor microenvironment for cancer therapy. |
title | Effective targeting of the tumor microenvironment for cancer therapy. |
title_full | Effective targeting of the tumor microenvironment for cancer therapy. |
title_fullStr | Effective targeting of the tumor microenvironment for cancer therapy. |
title_full_unstemmed | Effective targeting of the tumor microenvironment for cancer therapy. |
title_short | Effective targeting of the tumor microenvironment for cancer therapy. |
title_sort | effective targeting of the tumor microenvironment for cancer therapy |
work_keys_str_mv | AT jiangp effectivetargetingofthetumormicroenvironmentforcancertherapy AT lix effectivetargetingofthetumormicroenvironmentforcancertherapy AT thompsonc effectivetargetingofthetumormicroenvironmentforcancertherapy AT huangz effectivetargetingofthetumormicroenvironmentforcancertherapy AT araizaf effectivetargetingofthetumormicroenvironmentforcancertherapy AT osgoodr effectivetargetingofthetumormicroenvironmentforcancertherapy AT weig effectivetargetingofthetumormicroenvironmentforcancertherapy AT feldmannm effectivetargetingofthetumormicroenvironmentforcancertherapy AT frostg effectivetargetingofthetumormicroenvironmentforcancertherapy AT shepardh effectivetargetingofthetumormicroenvironmentforcancertherapy |